SlideShare a Scribd company logo
1 of 39
RESEARCH PROCESS IN PHCA -PHARMACOECONOMICS ,[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Preview
PHARMACOECONOMICS RESEARCH ,[object Object],[object Object],[object Object],[object Object],[object Object]
VALUE Health Outcome Cost
USE OF PHARMACOECONOMIC RESEARCH ,[object Object],[object Object],[object Object],[object Object],[object Object]
NEEDS TO MONITOR VALUE OF PHARMACEUTICALS ,[object Object],[object Object],[object Object],[object Object]
TYPES OF PHARMACOECONOMIC EVALUATION ,[object Object],[object Object],[object Object],[object Object],[object Object]
COMPARING PHARMACOECONOMIC METHODOLOGIES ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
STEPS FOR CONDUCTING A PHARMACOECONOMIC EVALUATION ,[object Object],[object Object],[object Object],[object Object]
DEFINE THE PROBLEM AND STATE THE OBJECTIVE ,[object Object],[object Object],[object Object],[object Object],[object Object]
PERSPECTIVE ,[object Object],[object Object],[object Object],[object Object]
PERSPECTIVE ,[object Object]
IDENTIFYING ALTERNATIVE INTERVENTIONS ,[object Object]
IDENTIFYING ALTERNATIVE INTERVENTIONS ,[object Object]
IDENTIFY AND MEASURE OUTCOMES OF EACH ALTERNATIVE INTERVENTION ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
OUTCOMES ,[object Object],[object Object],[object Object]
IDENTIFYING,MEASUREMENT AND VALUATION OF COSTS ,[object Object],[object Object]
IDENTIFYING RELEVANT COSTS ,[object Object],[object Object]
COSTS ,[object Object],[object Object],[object Object]
Costs can be described in many ways ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
MEASURING COSTS ,[object Object],[object Object]
VALUING COSTS ,[object Object]
SENSITIVITY ANALYSIS ,[object Object],[object Object]
DISCOUNTING ,[object Object],[object Object]
COST-MINIMIZATION ANALYSIS (CMA) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
COST-MINIMIZATION ANALYSIS (CMA) ,[object Object]
Cost-Minimization Analysis of Once-Weekly Versus Thrice-Weekly Epoetin Alfa for Chemotherapy-Related Anemia ,[object Object],[object Object],[object Object]
Cost-Minimization Analysis of Once-Weekly Versus Thrice-Weekly Epoetin Alfa for Chemotherapy-Related Anemia ,[object Object],[object Object],[object Object],[object Object]
Cost-Minimization Analysis of Once-Weekly Versus Thrice-Weekly Epoetin Alfa for Chemotherapy-Related Anemia ,[object Object],[object Object],[object Object],[object Object],[object Object]
COST-EFFECTIVENESS ANALYSIS (CEA) ,[object Object],[object Object],[object Object]
COST-EFFECTIVENESS ANALYSIS (CEA) ,[object Object],$43/ADDITIONAL SUCCESSFUL CASE TREATED $122/SUCCESFUL CASE 0.78 $95 C $260/ADDITIONAL SUCCESSFUL CASE TREATED $187/SUCCESFUL CASE 0.80 $150 B $155/SUCCESFUL CASE 0.55 $85 A ICER Average cost effectiveness ratio Outcome (Success rate) Average cost per patient Alternative
COST-BENEFIT ANALYSIS (CBA) ,[object Object],[object Object],[object Object],[object Object]
COST-BENEFIT ANALYSIS (CBA) ,[object Object],[object Object],[object Object]
COST-UTILITY ANALYSIS (CUA) ,[object Object],[object Object],[object Object],[object Object],[object Object]
COST-UTILITY ANALYSIS (CUA) ,[object Object],[object Object],[object Object],[object Object],[object Object]
COST-CONSEQUENCE ANALYSIS (CCA) ,[object Object],- - - - Cases successfully treated - - - - Clinical - - -- - Quality of life (QALY) - - - - Consequences - - - - Productivity (lost days/episode) - - - - Caregiver time - - - - Indirect - - - - Transportation - - - - Direct Non Medical - - - - Hospitalizations - - - - Physician costs - - - - Drug therapy Costs Units  Costs Units  Direct Medical Drug B Drug A Cost (per Patient)
COST-CONSEQUENCE ANALYSIS (CCA) ,[object Object],[object Object],[object Object]
JOURNALS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
REFERENCES ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

More Related Content

What's hot

Studies in health economics
Studies in health economicsStudies in health economics
Studies in health economicsTanveerRehman4
 
Cost Benefit Analysis in Health Care
Cost Benefit Analysis in Health CareCost Benefit Analysis in Health Care
Cost Benefit Analysis in Health CarePrabesh Ghimire
 
Quality use medicine
Quality use medicineQuality use medicine
Quality use medicineFARAZULHODA
 
Cost Minimization Analysis in Health Care
Cost Minimization Analysis in Health CareCost Minimization Analysis in Health Care
Cost Minimization Analysis in Health CarePrabesh Ghimire
 
Pharmacoeconomics (Basics for MD Pharmacology)
Pharmacoeconomics (Basics for MD Pharmacology)Pharmacoeconomics (Basics for MD Pharmacology)
Pharmacoeconomics (Basics for MD Pharmacology)Dr. Advaitha MV
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
PharmacoeconomicsZainab&Sons
 
Pharmacoeconomics In India
Pharmacoeconomics In IndiaPharmacoeconomics In India
Pharmacoeconomics In IndiaSameer Shete
 
Pharmacoeconomics Cost utility analysis
Pharmacoeconomics Cost utility analysisPharmacoeconomics Cost utility analysis
Pharmacoeconomics Cost utility analysisMohammed Mohammed
 
Pharmacoeconomics by harsh
Pharmacoeconomics by harshPharmacoeconomics by harsh
Pharmacoeconomics by harshHarsh Yadav
 
Pharmacoeconomics 1
Pharmacoeconomics 1Pharmacoeconomics 1
Pharmacoeconomics 1AmmarJassim4
 
Cost effectiveness analysis - seminar kmu peshawar
Cost effectiveness analysis - seminar kmu peshawarCost effectiveness analysis - seminar kmu peshawar
Cost effectiveness analysis - seminar kmu peshawarAamer Naseer
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomicssalim82
 
Quality Use of Medicines
Quality Use of MedicinesQuality Use of Medicines
Quality Use of Medicineskbaskett
 

What's hot (20)

Studies in health economics
Studies in health economicsStudies in health economics
Studies in health economics
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Cost Utility Analysis
Cost Utility AnalysisCost Utility Analysis
Cost Utility Analysis
 
Cost Benefit Analysis in Health Care
Cost Benefit Analysis in Health CareCost Benefit Analysis in Health Care
Cost Benefit Analysis in Health Care
 
Pharmacoeconomics ii
Pharmacoeconomics iiPharmacoeconomics ii
Pharmacoeconomics ii
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Quality use medicine
Quality use medicineQuality use medicine
Quality use medicine
 
Cost Minimization Analysis in Health Care
Cost Minimization Analysis in Health CareCost Minimization Analysis in Health Care
Cost Minimization Analysis in Health Care
 
Pharmacoeconomics (Basics for MD Pharmacology)
Pharmacoeconomics (Basics for MD Pharmacology)Pharmacoeconomics (Basics for MD Pharmacology)
Pharmacoeconomics (Basics for MD Pharmacology)
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmacoeconomics In India
Pharmacoeconomics In IndiaPharmacoeconomics In India
Pharmacoeconomics In India
 
Pharmacoeconomics Cost utility analysis
Pharmacoeconomics Cost utility analysisPharmacoeconomics Cost utility analysis
Pharmacoeconomics Cost utility analysis
 
Pharmacoeconomics by harsh
Pharmacoeconomics by harshPharmacoeconomics by harsh
Pharmacoeconomics by harsh
 
Pharmacoeconomics 1
Pharmacoeconomics 1Pharmacoeconomics 1
Pharmacoeconomics 1
 
Cost effectiveness analysis - seminar kmu peshawar
Cost effectiveness analysis - seminar kmu peshawarCost effectiveness analysis - seminar kmu peshawar
Cost effectiveness analysis - seminar kmu peshawar
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Health economics
Health economicsHealth economics
Health economics
 
Pharmacoeconomics
Pharmacoeconomics Pharmacoeconomics
Pharmacoeconomics
 
Quality Use of Medicines
Quality Use of MedicinesQuality Use of Medicines
Quality Use of Medicines
 

Similar to Pharmacoeconomics1

Pharmacoeconomics.ppt
Pharmacoeconomics.pptPharmacoeconomics.ppt
Pharmacoeconomics.pptPabitra Thapa
 
Pharmacoeconomics1
Pharmacoeconomics1Pharmacoeconomics1
Pharmacoeconomics1jinender16
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
PharmacoeconomicsIjeh Cyril
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
PharmacoeconomicsZainab&Sons
 
Pharmacoeconomics ppt.
Pharmacoeconomics ppt.Pharmacoeconomics ppt.
Pharmacoeconomics ppt.shahvijita
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
PharmacoeconomicsAhmad Ali
 
Seminar pharmacoeconomics
Seminar pharmacoeconomicsSeminar pharmacoeconomics
Seminar pharmacoeconomicsSameerKhasbage
 
Economicevaluation 08.Pptx
Economicevaluation 08.PptxEconomicevaluation 08.Pptx
Economicevaluation 08.Pptxrlh4
 
Outcomes, health economics and pharmacoeconomics
Outcomes, health economics and  pharmacoeconomicsOutcomes, health economics and  pharmacoeconomics
Outcomes, health economics and pharmacoeconomicsDureshahwar khan
 
lect_3_4_schwartzman_economic_analyses_tb_course_2015.ppt
lect_3_4_schwartzman_economic_analyses_tb_course_2015.pptlect_3_4_schwartzman_economic_analyses_tb_course_2015.ppt
lect_3_4_schwartzman_economic_analyses_tb_course_2015.pptDhanang Nugraha
 
pharmacoeconomic_models.pdf
pharmacoeconomic_models.pdfpharmacoeconomic_models.pdf
pharmacoeconomic_models.pdfKRIMSExamination
 
TOPIC-5-Pharmacoeconomics (1).pptx
TOPIC-5-Pharmacoeconomics (1).pptxTOPIC-5-Pharmacoeconomics (1).pptx
TOPIC-5-Pharmacoeconomics (1).pptxMohamedAdelSarhan1
 

Similar to Pharmacoeconomics1 (20)

Pharmaeconomic
Pharmaeconomic Pharmaeconomic
Pharmaeconomic
 
Pharmacoeconomics.ppt
Pharmacoeconomics.pptPharmacoeconomics.ppt
Pharmacoeconomics.ppt
 
Pharmacoeconomics1
Pharmacoeconomics1Pharmacoeconomics1
Pharmacoeconomics1
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmaconomics
PharmaconomicsPharmaconomics
Pharmaconomics
 
Pharmaconomics
PharmaconomicsPharmaconomics
Pharmaconomics
 
Pharmacoeconomics seminar
Pharmacoeconomics seminarPharmacoeconomics seminar
Pharmacoeconomics seminar
 
Pharmacoeconomics ppt.
Pharmacoeconomics ppt.Pharmacoeconomics ppt.
Pharmacoeconomics ppt.
 
Pharmaeconomic
Pharmaeconomic Pharmaeconomic
Pharmaeconomic
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Seminar pharmacoeconomics
Seminar pharmacoeconomicsSeminar pharmacoeconomics
Seminar pharmacoeconomics
 
Economicevaluation 08.Pptx
Economicevaluation 08.PptxEconomicevaluation 08.Pptx
Economicevaluation 08.Pptx
 
Outcomes, health economics and pharmacoeconomics
Outcomes, health economics and  pharmacoeconomicsOutcomes, health economics and  pharmacoeconomics
Outcomes, health economics and pharmacoeconomics
 
Pharmaeconomics
Pharmaeconomics Pharmaeconomics
Pharmaeconomics
 
lect_3_4_schwartzman_economic_analyses_tb_course_2015.ppt
lect_3_4_schwartzman_economic_analyses_tb_course_2015.pptlect_3_4_schwartzman_economic_analyses_tb_course_2015.ppt
lect_3_4_schwartzman_economic_analyses_tb_course_2015.ppt
 
pharmacoeconomic_models.pdf
pharmacoeconomic_models.pdfpharmacoeconomic_models.pdf
pharmacoeconomic_models.pdf
 
TOPIC-5-Pharmacoeconomics (1).pptx
TOPIC-5-Pharmacoeconomics (1).pptxTOPIC-5-Pharmacoeconomics (1).pptx
TOPIC-5-Pharmacoeconomics (1).pptx
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 

More from jinender16

Seminar Jinender
Seminar  JinenderSeminar  Jinender
Seminar Jinenderjinender16
 
Patient Attitude Towards Gifts To Physicians
Patient Attitude Towards Gifts To PhysiciansPatient Attitude Towards Gifts To Physicians
Patient Attitude Towards Gifts To Physiciansjinender16
 
Pseudoephedrine
PseudoephedrinePseudoephedrine
Pseudoephedrinejinender16
 
Direct To Consumer Advertising Of Prescription Drugs Pharmaceutical Industry
Direct To Consumer Advertising Of Prescription Drugs Pharmaceutical IndustryDirect To Consumer Advertising Of Prescription Drugs Pharmaceutical Industry
Direct To Consumer Advertising Of Prescription Drugs Pharmaceutical Industryjinender16
 
Poster Jinender
Poster JinenderPoster Jinender
Poster Jinenderjinender16
 

More from jinender16 (9)

ISPOR
ISPORISPOR
ISPOR
 
Poster
PosterPoster
Poster
 
Seminar Jinender
Seminar  JinenderSeminar  Jinender
Seminar Jinender
 
APha Poster
APha PosterAPha Poster
APha Poster
 
Patient Attitude Towards Gifts To Physicians
Patient Attitude Towards Gifts To PhysiciansPatient Attitude Towards Gifts To Physicians
Patient Attitude Towards Gifts To Physicians
 
Singapore
SingaporeSingapore
Singapore
 
Pseudoephedrine
PseudoephedrinePseudoephedrine
Pseudoephedrine
 
Direct To Consumer Advertising Of Prescription Drugs Pharmaceutical Industry
Direct To Consumer Advertising Of Prescription Drugs Pharmaceutical IndustryDirect To Consumer Advertising Of Prescription Drugs Pharmaceutical Industry
Direct To Consumer Advertising Of Prescription Drugs Pharmaceutical Industry
 
Poster Jinender
Poster JinenderPoster Jinender
Poster Jinender
 

Recently uploaded

Contemporary Economic Issues Facing the Filipino Entrepreneur (1).pptx
Contemporary Economic Issues Facing the Filipino Entrepreneur (1).pptxContemporary Economic Issues Facing the Filipino Entrepreneur (1).pptx
Contemporary Economic Issues Facing the Filipino Entrepreneur (1).pptxMarkAnthonyAurellano
 
APRIL2024_UKRAINE_xml_0000000000000 .pdf
APRIL2024_UKRAINE_xml_0000000000000 .pdfAPRIL2024_UKRAINE_xml_0000000000000 .pdf
APRIL2024_UKRAINE_xml_0000000000000 .pdfRbc Rbcua
 
India Consumer 2024 Redacted Sample Report
India Consumer 2024 Redacted Sample ReportIndia Consumer 2024 Redacted Sample Report
India Consumer 2024 Redacted Sample ReportMintel Group
 
Digital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdfDigital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdfJos Voskuil
 
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCRashishs7044
 
Call Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / Ncr
Call Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / NcrCall Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / Ncr
Call Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / Ncrdollysharma2066
 
Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...Seta Wicaksana
 
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCRashishs7044
 
Ms Motilal Padampat Sugar Mills vs. State of Uttar Pradesh & Ors. - A Milesto...
Ms Motilal Padampat Sugar Mills vs. State of Uttar Pradesh & Ors. - A Milesto...Ms Motilal Padampat Sugar Mills vs. State of Uttar Pradesh & Ors. - A Milesto...
Ms Motilal Padampat Sugar Mills vs. State of Uttar Pradesh & Ors. - A Milesto...ShrutiBose4
 
Intro to BCG's Carbon Emissions Benchmark_vF.pdf
Intro to BCG's Carbon Emissions Benchmark_vF.pdfIntro to BCG's Carbon Emissions Benchmark_vF.pdf
Intro to BCG's Carbon Emissions Benchmark_vF.pdfpollardmorgan
 
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCRashishs7044
 
Future Of Sample Report 2024 | Redacted Version
Future Of Sample Report 2024 | Redacted VersionFuture Of Sample Report 2024 | Redacted Version
Future Of Sample Report 2024 | Redacted VersionMintel Group
 
Memorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQMMemorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQMVoces Mineras
 
Annual General Meeting Presentation Slides
Annual General Meeting Presentation SlidesAnnual General Meeting Presentation Slides
Annual General Meeting Presentation SlidesKeppelCorporation
 
PSCC - Capability Statement Presentation
PSCC - Capability Statement PresentationPSCC - Capability Statement Presentation
PSCC - Capability Statement PresentationAnamaria Contreras
 
Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...
Global Scenario On Sustainable  and Resilient Coconut Industry by Dr. Jelfina...Global Scenario On Sustainable  and Resilient Coconut Industry by Dr. Jelfina...
Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...ictsugar
 
Cybersecurity Awareness Training Presentation v2024.03
Cybersecurity Awareness Training Presentation v2024.03Cybersecurity Awareness Training Presentation v2024.03
Cybersecurity Awareness Training Presentation v2024.03DallasHaselhorst
 
International Business Environments and Operations 16th Global Edition test b...
International Business Environments and Operations 16th Global Edition test b...International Business Environments and Operations 16th Global Edition test b...
International Business Environments and Operations 16th Global Edition test b...ssuserf63bd7
 

Recently uploaded (20)

Contemporary Economic Issues Facing the Filipino Entrepreneur (1).pptx
Contemporary Economic Issues Facing the Filipino Entrepreneur (1).pptxContemporary Economic Issues Facing the Filipino Entrepreneur (1).pptx
Contemporary Economic Issues Facing the Filipino Entrepreneur (1).pptx
 
APRIL2024_UKRAINE_xml_0000000000000 .pdf
APRIL2024_UKRAINE_xml_0000000000000 .pdfAPRIL2024_UKRAINE_xml_0000000000000 .pdf
APRIL2024_UKRAINE_xml_0000000000000 .pdf
 
India Consumer 2024 Redacted Sample Report
India Consumer 2024 Redacted Sample ReportIndia Consumer 2024 Redacted Sample Report
India Consumer 2024 Redacted Sample Report
 
Digital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdfDigital Transformation in the PLM domain - distrib.pdf
Digital Transformation in the PLM domain - distrib.pdf
 
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
8447779800, Low rate Call girls in Shivaji Enclave Delhi NCR
 
Call Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / Ncr
Call Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / NcrCall Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / Ncr
Call Girls in DELHI Cantt, ( Call Me )-8377877756-Female Escort- In Delhi / Ncr
 
Japan IT Week 2024 Brochure by 47Billion (English)
Japan IT Week 2024 Brochure by 47Billion (English)Japan IT Week 2024 Brochure by 47Billion (English)
Japan IT Week 2024 Brochure by 47Billion (English)
 
Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...Ten Organizational Design Models to align structure and operations to busines...
Ten Organizational Design Models to align structure and operations to busines...
 
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
8447779800, Low rate Call girls in Uttam Nagar Delhi NCR
 
Ms Motilal Padampat Sugar Mills vs. State of Uttar Pradesh & Ors. - A Milesto...
Ms Motilal Padampat Sugar Mills vs. State of Uttar Pradesh & Ors. - A Milesto...Ms Motilal Padampat Sugar Mills vs. State of Uttar Pradesh & Ors. - A Milesto...
Ms Motilal Padampat Sugar Mills vs. State of Uttar Pradesh & Ors. - A Milesto...
 
Intro to BCG's Carbon Emissions Benchmark_vF.pdf
Intro to BCG's Carbon Emissions Benchmark_vF.pdfIntro to BCG's Carbon Emissions Benchmark_vF.pdf
Intro to BCG's Carbon Emissions Benchmark_vF.pdf
 
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
8447779800, Low rate Call girls in Kotla Mubarakpur Delhi NCR
 
Future Of Sample Report 2024 | Redacted Version
Future Of Sample Report 2024 | Redacted VersionFuture Of Sample Report 2024 | Redacted Version
Future Of Sample Report 2024 | Redacted Version
 
Memorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQMMemorándum de Entendimiento (MoU) entre Codelco y SQM
Memorándum de Entendimiento (MoU) entre Codelco y SQM
 
Annual General Meeting Presentation Slides
Annual General Meeting Presentation SlidesAnnual General Meeting Presentation Slides
Annual General Meeting Presentation Slides
 
PSCC - Capability Statement Presentation
PSCC - Capability Statement PresentationPSCC - Capability Statement Presentation
PSCC - Capability Statement Presentation
 
Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...
Global Scenario On Sustainable  and Resilient Coconut Industry by Dr. Jelfina...Global Scenario On Sustainable  and Resilient Coconut Industry by Dr. Jelfina...
Global Scenario On Sustainable and Resilient Coconut Industry by Dr. Jelfina...
 
Enjoy ➥8448380779▻ Call Girls In Sector 18 Noida Escorts Delhi NCR
Enjoy ➥8448380779▻ Call Girls In Sector 18 Noida Escorts Delhi NCREnjoy ➥8448380779▻ Call Girls In Sector 18 Noida Escorts Delhi NCR
Enjoy ➥8448380779▻ Call Girls In Sector 18 Noida Escorts Delhi NCR
 
Cybersecurity Awareness Training Presentation v2024.03
Cybersecurity Awareness Training Presentation v2024.03Cybersecurity Awareness Training Presentation v2024.03
Cybersecurity Awareness Training Presentation v2024.03
 
International Business Environments and Operations 16th Global Edition test b...
International Business Environments and Operations 16th Global Edition test b...International Business Environments and Operations 16th Global Edition test b...
International Business Environments and Operations 16th Global Edition test b...
 

Pharmacoeconomics1

  • 1.
  • 2.
  • 3.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.